These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15588866)

  • 1. No correlation between trisomy 13 and FLT3 duplication in acute myeloid leukemia.
    Powell H; Curtis A; Bown N; Taylor P
    Cancer Genet Cytogenet; 2005 Jan; 156(1):92-3. PubMed ID: 15588866
    [No Abstract]   [Full Text] [Related]  

  • 2. Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation.
    Ferrara F; Vicari L; Festa B; Di Noto R; Pane F; Sebastio L; Cimino R
    Haematologica; 1995; 80(5):434-6. PubMed ID: 8566885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches].
    Spiekermann K; Hiddemann W; Schnittger S
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1020-5. PubMed ID: 15830315
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.
    Scholl S; Loncarevic IF; Krause C; Kunert C; Clement JH; Höffken K
    Leuk Res; 2005 Jul; 29(7):849-53. PubMed ID: 15921740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
    Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
    Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.
    Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS
    Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia.
    Matsuno N; Nanri T; Kawakita T; Mitsuya H; Asou N
    Leukemia; 2005 Mar; 19(3):480-1. PubMed ID: 15625552
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathophysiology and treatment of acute myeloid leukemia].
    Naoe J
    Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
    Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
    Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLT3 inhibition as tailored therapy for acute myeloid leukemia.
    Martinelli G; Piccaluga PP; Lo Coco F
    Haematologica; 2003 Jan; 88(1):4-8. PubMed ID: 12551818
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6.
    Takahashi S; Harigae H; Ishii KK; Inomata M; Fujiwara T; Yokoyama H; Ishizawa K; Kameoka J; Licht JD; Sasaki T; Kaku M
    Leuk Res; 2005 Aug; 29(8):893-9. PubMed ID: 15978940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3 Inhibitors in the Treatment of AML.
    Gilliland DG
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):708-10. PubMed ID: 16163256
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia.
    Aleskog A; Höglund M; Pettersson J; Hermansson M; Larsson R; Lindhagen E
    Leuk Res; 2005 Sep; 29(9):1079-81. PubMed ID: 16038735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.
    Murati A; Adélaïde J; Popovici C; Mozziconacci MJ; Arnoulet C; Lafage-Pochitaloff M; Sainty D; Birnbaum D; Chaffanet M
    Int J Mol Med; 2003 Oct; 12(4):423-8. PubMed ID: 12964013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
    Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
    Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
    Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
    J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.
    Gagyi E; Horváth E; Bödör C; Timár B; Matolcsy A; Pávai Z
    Rom J Morphol Embryol; 2006; 47(4):331-7. PubMed ID: 17392978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
    de Labarthe A; Pautas C; Thomas X; de Botton S; Bordessoule D; Tilly H; de Revel T; Bastard C; Preudhomme C; Michallet M; Fenaux P; Bastie JN; Socié G; Cordonnier C; Dombret H;
    Bone Marrow Transplant; 2005 Apr; 35(8):767-73. PubMed ID: 15735660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3.
    Smith ML; Arch R; Smith LL; Bainton N; Neat M; Taylor C; Bonnet D; Cavenagh JD; Andrew Lister T; Fitzgibbon J
    Br J Haematol; 2005 Feb; 128(3):318-23. PubMed ID: 15667533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.